Search details
1.
Pathological Effects of Apalutamide in Lower-risk Prostate Cancer: Results From a Phase II Clinical Trial.
J Urol
; 209(2): 354-363, 2023 02.
Article
in English
| MEDLINE | ID: mdl-36621991
2.
Targeting backdoor androgen synthesis through AKR1C3 inhibition: A presurgical hormonal ablative neoadjuvant trial in high-risk localized prostate cancer.
Prostate
; 81(7): 418-426, 2021 05.
Article
in English
| MEDLINE | ID: mdl-33755225
3.
Reply by Authors.
J Urol
; 209(2): 362-363, 2023 02.
Article
in English
| MEDLINE | ID: mdl-36621992
4.
Bipolar androgen therapy plus olaparib in men with metastatic castration-resistant prostate cancer.
Prostate Cancer Prostatic Dis
; 26(1): 194-200, 2023 03.
Article
in English
| MEDLINE | ID: mdl-36564459
5.
A combined, multimodal intervention for individuals with dementia.
Res Gerontol Nurs
; 4(1): 64-75, 2011 Jan.
Article
in English
| MEDLINE | ID: mdl-20509596
Results
1 -
5
de 5
1
Next >
>>